Healthy Returns: J&J cell therapy gains edge over Bristol Myers rival
J&J's cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to AI.
Stay updated with breaking news from Bruce Darrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
J&J's cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to AI.
J&J’s cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to...
Becker's is delighted to name 46 hospital and health system chief digital officers to know.
Mount Sinai Health System appoints interim CIO, Dr. Bruce Darrow, to fill vacancy left by previous IT leader's departure for Northwell Health. Learn more.
Misconceptions about how the Trusted Exchange Framework and Common Agreement (TEFCA) will be executed to create a nationwide EHR exchange have been clarified after speaking with Mount Sinai's deputy CIO.